Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,413 | -98,298 | -14,123 | -8,084 | N/A |
| Depreciation Amortization | 7 | 11,905 | 50 | 328 | N/A |
| Income taxes - deferred | 7 | -9,479 | -745 | N/A | N/A |
| Accounts payable and accrued liabilities | 751 | 2,406 | 4,540 | -312 | N/A |
| Other Working Capital | 930 | 2,600 | 5,657 | -1,020 | N/A |
| Other Operating Activity | 160 | 82,145 | -268 | 4,012 | 0 |
| Operating Cash Flow | $-7,560 | $-8,721 | $-4,889 | $-5,076 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,354 | N/A | N/A | 5,230 | N/A |
| Common Stock Issued | 5,187 | 19,082 | 0 | N/A | N/A |
| Common Stock Repurchased | N/A | -7 | 0 | N/A | N/A |
| Other Financing Activity | -588 | -13,118 | 1,865 | 0 | 0 |
| Financing Cash Flow | $5,953 | $5,956 | $1,865 | $5,230 | $N/A |
| Beginning Cash Position | 3,138 | 5,902 | 1,028 | 175 | N/A |
| End Cash Position | 1,531 | 3,138 | 6,602 | 329 | N/A |
| Net Cash Flow | $-1,607 | $-2,765 | $-3,023 | $154 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,560 | -8,721 | -4,889 | -5,076 | N/A |
| Free Cash Flow | -7,560 | -8,721 | -4,889 | -5,076 | 0 |